Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 9,791	$ 3,154	$ 20,069	$ 10,763
General and administrative	2,807	2,700	8,698	7,500
In-process R&D	0	0	0	50,618
Total operating expenses	12,598	5,854	28,767	68,881
Loss from operations	(12,598)	(5,854)	(28,767)	(68,881)
Other income (expense), net	623	(121)	1,136	(306)
Loss before income tax expense	(11,975)	(5,975)	(27,631)	(69,187)
Income tax expense	0	0	0	(13)
Net loss	$ (11,975)	$ (5,975)	$ (27,631)	$ (69,200)
Net loss per share - basic and diluted (in dollars per share)	$ (0.12)	$ (0.10)	$ (0.27)	$ (1.26)
Basic and diluted weighted average shares outstanding (in shares)	101,010	61,694	100,939	55,003
Other comprehensive loss:
Net loss	$ (11,975)	$ (5,975)	$ (27,631)	$ (69,200)
Unrealized loss on marketable securities	(129)	0	(641)	0
Comprehensive loss	$ (12,104)	$ (5,975)	$ (28,272)	$ (69,200)